Hongxia Niu

1.2k total citations · 1 hit paper
38 papers, 840 citations indexed

About

Hongxia Niu is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Hongxia Niu has authored 38 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 17 papers in Immunology and 16 papers in Epidemiology. Recurrent topics in Hongxia Niu's work include Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (8 papers) and Antibiotic Resistance in Bacteria (7 papers). Hongxia Niu is often cited by papers focused on Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (8 papers) and Antibiotic Resistance in Bacteria (7 papers). Hongxia Niu collaborates with scholars based in China, United States and Norway. Hongxia Niu's co-authors include Ying Zhang, Bingdong Zhu, Peng Cui, Wanliang Shi, Wenhong Zhang, Shuo Zhang, Hongjuan Yu, Lina Hu, Xingming Ma and Yanping Luo and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Frontiers in Immunology.

In The Last Decade

Hongxia Niu

36 papers receiving 830 citations

Hit Papers

Bacterial persisters: molecular mechanisms and therapeuti... 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongxia Niu China 18 381 329 258 241 116 38 840
Jonathan T. Sullivan United States 10 290 0.8× 356 1.1× 204 0.8× 204 0.8× 59 0.5× 17 668
Juliane Lippmann Germany 10 344 0.9× 289 0.9× 380 1.5× 334 1.4× 65 0.6× 11 805
Marek Fol Poland 18 380 1.0× 351 1.1× 277 1.1× 305 1.3× 76 0.7× 41 1.0k
Beverlie Baquir United States 12 337 0.9× 338 1.0× 272 1.1× 225 0.9× 273 2.4× 14 981
Nicole Pecora United States 15 432 1.1× 430 1.3× 352 1.4× 305 1.3× 176 1.5× 36 1.2k
Sherry L. Kurtz United States 15 318 0.8× 490 1.5× 334 1.3× 229 1.0× 63 0.5× 31 924
Qian Gao China 22 417 1.1× 532 1.6× 138 0.5× 337 1.4× 66 0.6× 43 1.2k
Nikki J. Wagner United States 15 166 0.4× 229 0.7× 162 0.6× 207 0.9× 103 0.9× 26 780
Ala‐Eddine Deghmane France 26 285 0.7× 292 0.9× 379 1.5× 1.2k 4.9× 104 0.9× 90 1.9k
Neelima Sukumar United States 12 368 1.0× 303 0.9× 155 0.6× 321 1.3× 60 0.5× 15 798

Countries citing papers authored by Hongxia Niu

Since Specialization
Citations

This map shows the geographic impact of Hongxia Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Niu more than expected).

Fields of papers citing papers by Hongxia Niu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxia Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Niu. The network helps show where Hongxia Niu may publish in the future.

Co-authorship network of co-authors of Hongxia Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxia Niu. A scholar is included among the top collaborators of Hongxia Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxia Niu. Hongxia Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Qingang, et al.. (2025). The immune mechanisms of the urinary tract against infections. Frontiers in Cellular and Infection Microbiology. 15. 1540149–1540149.
2.
Chen, Qiqi, et al.. (2025). Dynamic risk stratification and treatment optimization in sepsis: the role of NLPR. Frontiers in Pharmacology. 16. 1572677–1572677. 2 indexed citations
3.
Niu, Hongxia, et al.. (2024). Rapamycin improves the long-term T-cell memory and protective efficacy of tuberculosis subunit vaccine. Microbial Pathogenesis. 190. 106631–106631. 5 indexed citations
4.
Niu, Hongxia, et al.. (2024). Bacterial persisters: molecular mechanisms and therapeutic development. Signal Transduction and Targeted Therapy. 9(1). 174–174. 97 indexed citations breakdown →
5.
Niu, Hongxia, Qianqian Cao, Tingting Zhang, et al.. (2023). Construction and evaluation of a novel multi-antigenic Mycobacterium tuberculosis subunit vaccine candidate BfrB-GrpE/DPC. International Immunopharmacology. 124(Pt B). 111060–111060. 3 indexed citations
6.
Wang, Yanyan, Bing Liang, Wujun Chen, et al.. (2023). High antipersister activity of a promising new quinolone drug candidate in eradicating uropathogenic Escherichia coli persisters and persistent infection in mice. Journal of Applied Microbiology. 134(9). 3 indexed citations
7.
Xie, Tao, et al.. (2022). Optimizing the Boosting Schedule of Subunit Vaccines Consisting of BCG and “Non-BCG” Antigens to Induce Long-Term Immune Memory. Frontiers in Immunology. 13. 862726–862726. 7 indexed citations
8.
Niu, Hongxia, et al.. (2022). Pyrazinamide enhances persistence of T-cell memory induced by tuberculosis subunit vaccine LT70. Tuberculosis. 135. 102220–102220. 2 indexed citations
9.
Wang, Juan, Qianqian Cao, Fei Li, et al.. (2020). Identification of Novel Genes Involved in Escherichia coli Persistence to Tosufloxacin. Frontiers in Cellular and Infection Microbiology. 10. 581986–581986. 8 indexed citations
11.
Niu, Hongxia, Rebecca Yee, Peng Cui, et al.. (2017). Identification of Agents Active against Methicillin-Resistant Staphylococcus aureus USA300 from a Clinical Compound Library. Pathogens. 6(3). 44–44. 18 indexed citations
12.
Chen, Huiyu, Xun Liu, Xingming Ma, et al.. (2017). A New Rabbit-Skin Model to Evaluate Protective Efficacy of Tuberculosis Vaccines. Frontiers in Microbiology. 8. 842–842. 6 indexed citations
13.
Li, Jingjing, Hongxia Niu, Ruiying Li, et al.. (2017). Immunogenicity and protective efficacy of multistage vaccine candidates (Mtb8.4-HspX and HspX-Mtb8.4) against Mycobacterium tuberculosis infection in mice. International Immunopharmacology. 53. 83–89. 8 indexed citations
14.
Liu, Yang, Jinxiu Peng, Lina Hu, et al.. (2016). A multistage mycobacterium tuberculosis subunit vaccine LT70 including latency antigen Rv2626c induces long-term protection against tuberculosis. Human Vaccines & Immunotherapeutics. 12(7). 1–8. 40 indexed citations
15.
Niu, Hongxia, Peng Cui, Wanliang Shi, et al.. (2015). Identification of Anti-Persister Activity against Uropathogenic Escherichia coli from a Clinical Drug Library. Antibiotics. 4(2). 179–187. 29 indexed citations
16.
Niu, Hongxia, Peng Cui, Rebecca Yee, et al.. (2015). A Clinical Drug Library Screen Identifies Tosufloxacin as Being Highly Active against Staphylococcus aureus Persisters. Antibiotics. 4(3). 329–336. 21 indexed citations
17.
Niu, Hongxia, Jinxiu Peng, Xun Liu, et al.. (2015). Multi-Stage Tuberculosis Subunit Vaccine Candidate LT69 Provides High Protection against Mycobacterium tuberculosis Infection in Mice. PLoS ONE. 10(6). e0130641–e0130641. 29 indexed citations
18.
Pei, Hanjun, Yongjian Wu, Yuejin Yang, et al.. (2015). [Early clinical outcomes of percutaneous balloon aortic valvuloplasty in treating high-risk patients with severe aortic stenosis].. PubMed. 43(1). 34–8. 1 indexed citations
19.
Niu, Hongxia, Lina Hu, Bingxiang Wang, et al.. (2011). Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4–HspX. Vaccine. 29(51). 9451–9458. 61 indexed citations
20.
Niu, Hongxia, Wei Hua, Shu Zhang, et al.. (2007). Prevalence of Dyssynchrony Derived from Echocardiographic Criteria in Heart Failure Patients with Normal or Prolonged QRS Duration. Echocardiography. 24(4). 348–352. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026